Top

BMC Cardiovascular Disorders

Published in:

Open Access 01-12-2020 | Hypertension | Research article

Changes in the prevalence of measures associated with hypertension among Iranian adults according to classification by ACC/AHA guideline 2017

Authors: Mohsen Mirzaei, Masoud Mirzaei, Mojtaba Mirzaei, Behnam Bagheri

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Abstract

Background

Different definitions have been proposed to categorize hypertension. We aimed to investigate the difference in prevalence of measures associated with hypertension according to the American College of Cardiology/American Heart Association (ACC/AHA) criteria versus Joint National Committee 7 (JNC7) criteria.

Methods

We analyzed the data of 10,000 participants of Yazd Health Study (YaHS) aged 20–69 years. Blood pressure was measured three times with standard protocol defined by ACC/AHA. Prevalence of high blood pressure measure was compared in both definitions and absolute differences reported.

Results

The prevalence of high blood pressure in our measurement was 61.0% according to ACC/AHA, and 28.9% according to JNC 7. The prevalence of self-reported hypertension was 18.6%. Age and sex standardized prevalence rates of high blood pressure measure indicates a 2.4-fold increase in the prevalence rate (30.1% absolute difference) by the ACC/AHA guideline. While the prevalence increased in all age groups, the age group of 20–29 showed the highest relative increase by 3.6 times (10.6% vs. 38.1%). High blood pressure measure among people with diabetes increased from 45.8 to 75.3% with the ACC/AHA guideline. Of the people who had no past history of diagnosed hypertension (n = 7887), 55.1 and 22.7% had high blood pressure measure by ACC/AHA and JNC-7 guidelines, respectively. From JNC7 to ACC/AHA, the overall difference in unawareness about HTN increased by 32.4%.

Conclusion

Prevalence of hypertension associated measures increased over two folds by using the ACC/AHA criteria compared to JNC 7. Also, change in the criteria, reduces awareness of the disease and increases uncontrolled hypertension respectively. More research is needed to determine if the new definitions can affect management of hypertension in societies. Considering local priorities and implication of cost effective may improve implementation of new definitions for hypertension in different countries.

Danaei G, Lu Y, Singh GM, Carnahan E, Stevens GA, Cowan MJ, et al. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diab Endocrinol. 2014;2(8):634–47. https://doi.org/10.1016/S2213-8587(14)70102-0.CrossRef

Tran J, Mirzaei M. The population attributable fraction of stroke associated with high blood pressure in the Middle East and North Africa. J Neurol Sci. 2011;308(1–2):135–8. https://doi.org/10.1016/j.jns.2011.05.016.CrossRefPubMed

Saeed KMI. Prevalence of hypertension and associated factors in Jalalabad City, Nangarhar Province, Afghanistan. Central Asian J Global Health. 2015;4(1):134. https://doi.org/10.5195/cajgh.2015.134.CrossRef

Afsargharehbagh R, Rezaie-Keikhaie K, Rafiemanesh H, Balouchi A, Bouya S, Dehghan B. Hypertension and pre-hypertension among Iranian adults population: a meta-analysis of prevalence, awareness, treatment, and control. Curr Hypertens Rep. 2019;21(4):27. https://doi.org/10.1007/s11906-019-0933-z.CrossRefPubMed

Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980–2012: a systematic review. J Tehran Univ Heart Center. 2016;11(4):159–67.

Gakidou E, Afshin A, Abajobir AA, Abate KH, Abbafati C, Abbas KM, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1345–422. https://doi.org/10.1016/S0140-6736(17)32366-8.CrossRef

Bloch MJ. The worldwide prevalence of hypertension exceeds 1.3 billion. J Am Soc Hypertens. 2016;10(10):753–4. https://doi.org/10.1016/j.jash.2016.08.006.CrossRefPubMed

Carey RM, Whelton PK. Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology/American Heart Association hypertension guideline. Ann Intern Med. 2018;168(5):351–8. https://doi.org/10.7326/M17-3203.CrossRefPubMed

CR WPK, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, SM DP, Gidding S, Jamerson KA, Jones DW, EJ ML, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115. https://doi.org/10.1161/HYP.0000000000000065.CrossRef

10.

Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT Jr, et al. Potential US population impact of the 2017 ACC/AHA high blood pressure guideline. Circulation. 2018;137(2):109–18. https://doi.org/10.1161/CIRCULATIONAHA.117.032582.CrossRefPubMed

11.

Khera R, Lu Y, Lu J, Saxena A, Nasir K, Jiang L, et al. The impact of 2017 ACC/AHA guidelines on the prevalence of hypertension and eligibility for anti-hypertensive therapy in the United States and China. BMJ. 2018;11:362:k2357. https://doi.org/10.1136/bmj.k2357.CrossRef

12.

Miller CS, Glick M, Rhodus NL. 2017 hypertension guidelines: new opportunities and challenges. J Am Dent Assoc. 2018;149(4):229–31. https://doi.org/10.1016/j.adaj.2018.01.047.CrossRefPubMed

13.

Kibria GMA, Swasey K, Sharmeen A, Sakib MN, Burrowes V. Prevalence and associated factors of pre-hypertension and hypertension in Nepal: analysis of the Nepal demographic and health survey 2016. Health Sci Rep. 2018;1(10):e83. https://doi.org/10.1002/hsr2.83.CrossRefPubMedPubMedCentral

14.

Al Kibria GM, Swasey K, Choudhury A, Burrowes V, Stafford KA, Uddin SI, et al. The new 2017 ACC/AHA guideline for classification of hypertension: changes in the prevalence of hypertension among adults in Bangladesh. J Hum Hypertens. 2018;32(8):608.CrossRefPubMedPubMedCentral

15.

Mirzaei M, Salehi-Abargouei A, Mirzaei M, Mohsenpour MA. Cohort Profile: The Yazd Health Study (YaHS): a population-based study of adults aged 20–70 years (study design and baseline population data). Int J Epidemiol. 2017;47(3):697-8h. https://doi.org/10.1093/ije/dyx231.CrossRef

16.

Mirzaei M, Mirzaei M, Bagheri B, et al. Awareness, treatment, and control of hypertension and related factors in adult Iranian population. BMC Public Health. 2020;20:667. https://doi.org/10.1186/s12889-020-08831-1.CrossRefPubMedPubMedCentral

17.

Ogedegbe G, Pickering T. Principles and techniques of blood pressure measurement. Cardiol Clin. 2010;28(4):571–86. https://doi.org/10.1016/j.ccl.2010.07.006.CrossRefPubMedPubMedCentral

18.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–71. https://doi.org/10.1001/jama.289.19.2560.CrossRefPubMed

19.

Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):e127–248. https://doi.org/10.1016/j.jacc.2017.11.006.CrossRefPubMed

20.

Who EC. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (London). 2004;363(9403):157.CrossRef

21.

Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Khajeh E, et al. Awareness, treatment and control of pre-hypertension and hypertension among adults in Iran. Arch Iran Med. 2016;19(7):456–464. doi: 0161907/AIM.003.

22.

Malekzadeh MM, Etemadi A, Kamangar F, Khademi H, Golozar A, Islami F, et al. Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens. 2013;31(7):1364–71. https://doi.org/10.1097/HJH.0b013e3283613053.CrossRefPubMedPubMedCentral

23.

Asgari S, Khaloo P, Khalili D, Azizi F, Hadaegh F. Status of hypertension in Tehran: potential impact of the ACC/AHA 2017 and JNC7 guidelines, 2012–2015. Sci Rep. 2019;9(1):6382. https://doi.org/10.1038/s41598-019-42809-3.CrossRefPubMedPubMedCentral

24.

Lee JH, Kim S-H, Kang S-H, Cho JH, Cho Y, Oh I-Y, et al. Blood pressure control and cardiovascular outcomes: real-world implications of the 2017 ACC/AHA hypertension guideline. Sci Rep. 2018;8(1):13155. https://doi.org/10.1038/s41598-018-31549-5.CrossRefPubMedPubMedCentral

25.

Li D, Zeng X, Huang Y, Lei H, Li G, Zhang N, et al. Increased risk of hypertension in young adults in Southwest China: impact of the 2017 ACC/AHA high blood pressure guideline. Curr Hypertens Rep. 2019;21(3):21. https://doi.org/10.1007/s11906-019-0926-y.CrossRefPubMed

26.

Gauer R, Larocque J. JNC 8: relaxing the standards. Am Fam Physician. 2014;90(7):449–52.PubMed

27.

. Available from: https://www.acc.org/latest-in-cardiology/articles/2019/04/04/12/50/similarities-and-differences-between-the-2017-acc-aha-bp-guideline-and-2017-ada-diabetes-and-htn-position-statement. Accessed July 26, 2019.

28.

Group SR. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16. https://doi.org/10.1056/NEJMoa1511939.CrossRef

29.

Group AS. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575–85. https://doi.org/10.1056/NEJMoa1001286.CrossRef

30.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. https://doi.org/10.1093/eurheartj/ehy339.CrossRefPubMed

31.

Qaseem A, Wilt TJ, Rich R, Humphrey LL, Frost J, Forciea MA. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of family physicians. Ann Intern Med. 2017;166(6):430–7. https://doi.org/10.7326/M16-1785.CrossRefPubMed

32.

Spruill TM, Gerber LM, Schwartz JE, Pickering TG, Ogedegbe G. Race differences in the physical and psychological impact of hypertension labeling. Am J Hypertens. 2012;25(4):458–63. https://doi.org/10.1038/ajh.2011.258.CrossRefPubMed

33.

Leynen F, Backer GD, Pelfrene E, Clays E, Kittel F, Moreau M, et al. Increased absenteeism from work among aware and treated hypertensive and hypercholesterolaemic patients. Eur J Cardiovasc Prev Rehabil. 2006;13(2):261–7. https://doi.org/10.1097/01.hjr.0000194420.62379.de.CrossRefPubMed

34.

Stewart JC, France CR, Sheffield D. Hypertension awareness and pain reports: data from the NHANES III. Ann Behav Med. 2003;26(1):8–14. https://doi.org/10.1207/S15324796ABM2601_02.CrossRefPubMed

35.

Spruill TM, Feltheimer SD, Harlapur M, Schwartz JE, Ogedegbe G, Park Y, et al. Are there consequences of labeling patients with prehypertension? An experimental study of effects on blood pressure and quality of life. J Psychosom Res. 2013;74(5):433–8. https://doi.org/10.1016/j.jpsychcores.2013.01.009.CrossRefPubMedPubMedCentral

36.

Viera AJ, Lingley K, Esserman D. Effects of labeling patients as prehypertensive. J Am Board Fam Med. 2010;23(5):571–83. https://doi.org/10.3122/jabfm.2010.05.100047.CrossRefPubMed

37.

Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303(20):2043–50. https://doi.org/10.1001/jama.2010.650.CrossRefPubMed

Title: Changes in the prevalence of measures associated with hypertension among Iranian adults according to classification by ACC/AHA guideline 2017
Authors: Mohsen Mirzaei
Masoud Mirzaei
Mojtaba Mirzaei
Behnam Bagheri
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Hypertension
Hypertension
Published in: BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI: https://doi.org/10.1186/s12872-020-01657-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Changes in the prevalence of measures associated with hypertension among Iranian adults according to classification by ACC/AHA guideline 2017

Abstract

Background

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2020

Association between the ratio of serum n-3 to n-6 polyunsaturated fatty acids and acute coronary syndrome in non-obese patients with coronary risk factor: a multicenter cross-sectional study

The effects of body mass index on outcomes for patients undergoing surgical aortic valve replacement

Acute peripheral pulmonary embolism attributed to autoimmune haemolytic anaemia: a case report

Association of Dietary Inflammatory Index with cardiovascular disease in Kurdish adults: results of a prospective study on Ravansar non-communicable diseases

Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40–69 year olds

Recombinant Klotho protein enhances cholesterol efflux of THP-1 macrophage-derived foam cells via suppressing Wnt/β-catenin signaling pathway

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page